
PSNL
Healthcare · Diagnostics & Research · $1.70B market cap
$15.71-0.15 (-0.9%)Nov 13, 4:00 PM EST
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +1.8% over 90 days · 30-day revisions 1 up, 0 down
Beat estimates in 1 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 4, 2026 | After the close | -0.25 | -0.32 | -28.0% |
| Aug 4, 2026 | After the close | -0.25 | -0.30 | -20.0% |
| May 7, 2026 | After the close | -0.28 | -0.29 | -3.6% |
| Feb 26, 2026 | Time not confirmed | -0.31 | -0.26 | +16.1% |
| Nov 4, 2025 | After the close | -0.27 | -0.24 | +11.1% |
| Aug 5, 2025 | After the close | -0.24 | -0.23 | +4.2% |
| May 6, 2025 | After the close | -0.25 | -0.18 | +28.0% |
| Feb 26, 2025 | After the close | -0.26 | -0.23 | +12.9% |
| Nov 6, 2024 | After the close | -0.34 | -0.64 | -88.2% |
| Aug 7, 2024 | After the close | -0.38 | -0.24 | +36.8% |
| May 8, 2024 | After the close | -0.38 | -0.26 | +31.6% |
| Feb 28, 2024 | After the close | -0.50 | -0.54 | -8.0% |
| Nov 7, 2023 | After the close | -0.52 | -0.48 |
Personalis, Inc. develops, markets, and sells advanced cancer genomic tests and services in the United States and internationally. The company offers NeXT Personal, a tumor-informed liquid biopsy test for detection of minimal residual disease (MRD), therapy response and recurrence monitoring in solid tumor cancers; and ImmunoID NeXT, a tissue-based service that combines whole exome and whole transcriptome…
| +7.7% |
| Aug 8, 2023 | After the close | -0.54 | -0.50 | +7.4% |
| May 3, 2023 | After the close | -0.58 | -0.61 | -5.2% |
| Feb 23, 2023 | After the close | -0.64 | -0.67 | -4.7% |
| Nov 2, 2022 | After the close | -0.63 | -0.58 | +7.9% |
| Aug 3, 2022 | After the close | -0.58 | -0.60 | -3.4% |
| May 4, 2022 | After the close | -0.58 | -0.63 | -8.6% |
| Feb 24, 2022 | After the close | -0.50 | -0.45 | +10.0% |
| Nov 4, 2021 | Before the open | -0.42 | -0.40 | +4.8% |
| Aug 4, 2021 | After the close | -0.39 | -0.34 | +12.8% |
| May 5, 2021 | After the close | -0.36 | -0.29 | +19.4% |
| Feb 25, 2021 | After the close | -0.29 | -0.34 | -17.2% |
| Nov 5, 2020 | After the close | -0.28 | -0.27 | +3.6% |
| Aug 6, 2020 | After the close | -0.34 | -0.29 | +14.7% |
| May 7, 2020 | After the close | -0.25 | -0.29 | -16.0% |
| Mar 25, 2020 | After the close | -0.25 | -0.04 | +84.0% |
| Nov 13, 2019 | After the close | -0.25 | -0.17 | +32.0% |
| Aug 13, 2019 | After the close | -0.26 | -0.19 | +26.9% |
| Jun 20, 2019 | After the close | 0.00 | -0.70 | — |